DAFNA CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | SLNO | 53K | $3.58M |
 | ASND | 33K | $6.60M |
 | NGNE | 30K | $526.40K |
 | URGN | 28K | $548.92K |
 | CLDX | 25K | $634.28K |
 | INSP | 17K | $1.28M |
 | ALGN | 11K | $1.38M |
 | BNTX | 7K | $690.34K |
 | PODD | 7K | $2.12M |
Soleno Therapeutics, Inc.
SLNO
Shares Held
53K
Value
$3.58M
Ascendis Pharma A/S
ASND
Shares Held
33K
Value
$6.60M
Neurogene Inc.
NGNE
Shares Held
30K
Value
$526.40K
UroGen Pharma Ltd.
URGN
Shares Held
28K
Value
$548.92K
Celldex Therapeutics, Inc.
CLDX
Shares Held
25K
Value
$634.28K
Inspire Medical Systems, Inc.
INSP
Shares Held
17K
Value
$1.28M
Align Technology, Inc.
ALGN
Shares Held
11K
Value
$1.38M
BioNTech SE
BNTX
Shares Held
7K
Value
$690.34K
Insulet Corporation
PODD
Shares Held
7K
Value
$2.12M